Treatment of Panic Attacks
For acute panic attacks, use immediate grounding and breathing techniques, while for panic disorder with recurrent attacks, initiate cognitive behavioral therapy (CBT) as first-line treatment, with SSRIs (particularly paroxetine) or benzodiazepines (alprazolam) as pharmacologic options when needed. 1
Acute Management During a Panic Attack
Immediate interventions focus on preventing escalation and maintaining safety:
- Move the patient to a safe space where they are unlikely to injure themselves 2
- Provide reassurance that they are safe, but avoid constant reassurance or physical restraint 2
- Apply sensory grounding techniques to keep the person present in the moment: noticing environmental details (colors, textures, sounds), cognitive distractions (word games, counting backwards), or sensory-based distractors (flicking a rubber band on the wrist, feeling textured items) 2
- Implement breathing techniques such as diaphragmatic breathing to help regulate physiological arousal 2
A common pitfall is treating panic attacks like medical emergencies requiring sedation—most panic attacks resolve within minutes with supportive measures alone 2.
First-Line Treatment: Cognitive Behavioral Therapy
CBT is the evidence-based psychotherapy of choice for panic disorder and should include these core components:
- Psychoeducation about panic and anxiety, explaining the physiological fight-or-flight response 2, 1
- Diaphragmatic breathing techniques to counteract hyperventilation and restore normal respiratory patterns 2, 1
- Cognitive restructuring to address catastrophic thoughts and fear networks 2, 1
- Interoceptive exposure to desensitize patients to feared bodily sensations 2, 1
- In vivo exposure to feared situations that trigger panic 1
The evidence shows CBT produces significant improvements in panic attack frequency, PTSD severity, and overall distress 2. Treatment should continue for at least 9-12 months after recovery to prevent relapse 1.
Pharmacologic Treatment Options
SSRIs (Preferred Medication)
Paroxetine is FDA-approved for panic disorder and should be considered when pharmacotherapy is indicated 3:
- Effective for treating panic attacks characterized by palpitations, sweating, trembling, shortness of breath, chest pain, dizziness, and fear of losing control 3
- Long-term maintenance demonstrated in 3-month relapse prevention trials, with lower relapse rates compared to placebo 3
- Physician should periodically re-evaluate long-term usefulness for extended treatment 3
Benzodiazepines (Short-Term Use)
Alprazolam is FDA-approved for panic disorder but carries significant risks 4:
- Initial dosing: Start with 0.5 mg three times daily, may increase at 3-4 day intervals to maximum 4 mg/day in divided doses 4
- For panic disorder specifically: Doses of 1-10 mg daily were used in controlled trials, with mean dosage of 5-6 mg/day; some patients required up to 10 mg/day 4
- Critical warning: Risk of dependence increases with dose and duration; abrupt discontinuation must be avoided 4
- Tapering protocol: Decrease by no more than 0.5 mg every 3 days when discontinuing; some patients require even slower reduction 4
A major pitfall is using benzodiazepines as sole first-line treatment due to dependence risk—they should not replace CBT or SSRIs as primary therapy 1.
Adjunctive Interventions
Additional anxiety management strategies can augment primary treatment:
- Progressive muscle relaxation to reduce physiological tension 2, 1
- Mindfulness techniques that align with patient's cultural or religious practices 2, 5
- Regular cardiovascular exercise to reduce baseline anxiety 2
- Structured daily routines to prevent cognitive overload and minimize stress 2
- Graded exposure to anxiety-provoking tasks in stepwise fashion 2
Relaxation training may be considered as adjunctive treatment but should not replace evidence-based interventions 1.
Cultural Considerations
Cultural adaptation of CBT improves outcomes for specific populations:
- For Southeast Asian refugees: Incorporate culturally appropriate visualization (lotus blossom imagery), address "blocked wind" conceptualizations of panic, and consider treatment in culturally comfortable settings like Buddhist temples 2, 5
- Assessment of acculturation level is crucial—patients with lower acculturation benefit more from culturally adapted approaches 5
- Use culturally appropriate interpreters with mental health experience for accurate communication 5
The evidence demonstrates that culturally adapted CBT produces significant improvements in somatic sensations, panic attack frequency, and PTSD severity in refugee populations with treatment-resistant panic 2, 5.
Treatment Duration and Monitoring
Maintain treatment for adequate duration:
- Continue therapy for at least 9-12 months after recovery to prevent relapse 1
- For patients on alprazolam doses >4 mg/day, periodic reassessment and consideration of dose reduction is advised 4
- Patients in controlled trials were able to taper to 50% of maintenance dose after 3 months without loss of clinical benefit 4
Stopping treatment prematurely is a common pitfall—relapse rates increase significantly when treatment is discontinued before 9-12 months 1.
Differential Diagnosis Considerations
Rule out medical conditions that mimic panic attacks:
- In primary care settings with acute chest pain, look for pain affected by palpation, breathing, or movement (suggests non-cardiac origin) 2
- Panic attacks have sudden onset, build to peak rapidly, and include trembling, dizziness, derealization, paresthesias, and chills or hot flushes 2
- Failing to differentiate panic disorder from medical conditions is a critical pitfall that can delay appropriate treatment 1